LOREN ANDERSON: Open Payments
NPI 1982075339 · LARGO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,892 in 77 payments from 18 companies in 2025. Trend: 2023 $2,104 · 2024 $2,376 · 2025 $1,892
Food & beverage: $1,892
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $553 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $317 |
| Celltrion USA Inc. | 3 | $167 |
| Janssen Biotech, Inc. | 6 | $146 |
| QOL Medical, LLC | 5 | $129 |
| Lilly USA, LLC | 4 | $95 |
| PFIZER INC. | 5 | $88 |
| VIVUS LLC | 4 | $73 |
| Regeneron Healthcare Solutions, Inc. | 3 | $64 |
| Gilead Sciences, Inc. | 2 | $43 |
Products named: ENTYVIO, SKYRIZI, RINVOQ, TREMFYA, Sucraid, ZYMFENTRA, Linzess, OMVOH.
Industry payments across FL — which companies pay providers there.
